Zobrazeno 1 - 10
of 141
pro vyhledávání: '"George Sourvinos"'
Autor:
Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, Daniel Blazquez-Gamero, Ana Alarcon, Nicolas Bourgon, Ina Foulon, Jacques Fourgeaud, Anna Gonce, Christine E. Jones, Paul Klapper, André Krom, Tiziana Lazzarotto, Hermione Lyall, Paulo Paixao, Vassiliki Papaevangelou, Elisabeth Puchhammer, George Sourvinos, Pamela Vallely, Yves Ville, Ann Vossen
Publikováno v:
The Lancet Regional Health. Europe, Vol 40, Iss , Pp 100892- (2024)
Summary: Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0.64% global prevalence and a 17–20% chance of serious long-term effects in children. Since the last guidelines, our understanding, particularly regarding prim
Externí odkaz:
https://doaj.org/article/3d3e0584f9dd40aa946a4e4c0658a361
Publikováno v:
Journal of Clinical Virology Plus, Vol 3, Iss 1, Pp 100129- (2023)
The SARS-CoV-2 pandemic led to an urgent need for rapid diagnostic testing in order to inform timely patients’ management. This study aimed to assess the performance of the STANDARD™ M10 SARS-CoV-2 assay as a diagnostic tool for COVID-19. A total
Externí odkaz:
https://doaj.org/article/75e26eead11640239ec3256369276617
Autor:
Ahmed A. Al-Qahtani, Ioanna Pantazi, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, Eleni Vergadi, Christos Tsatsanis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundSARS-CoV-2 infects through the respiratory route and triggers inflammatory response by affecting multiple cell types including type II alveolar epithelial cells. SARS-CoV-2 triggers signals via its Spike (S) protein, which have been shown t
Externí odkaz:
https://doaj.org/article/e2e03719356341339118d6fd8cd9cdf3
Autor:
Christos Lionis, Elena Petelos, Manolis Linardakis, Athanasios Diamantakis, Emmanouil Symvoulakis, Maria-Nefeli Karkana, Marilena Kampa, Stergios A. Pirintsos, George Sourvinos, Elias Castanas
Publikováno v:
Diseases, Vol 11, Iss 3, p 105 (2023)
Introduction: The need for effective therapeutic regimens for non-critically ill patients during the COVID-19 pandemic remained largely unmet. Previous work has shown that a combination of three aromatic plants’ essential oils (CAPeo) (Thymbra capi
Externí odkaz:
https://doaj.org/article/b5eb7d1206914be0bd5b53908522228b
Autor:
Kassiani Mellou, Kyriaki Tryfinopoulou, Styliani Pappa, Kassiani Gkolfinopoulou, Sofia Papanikou, Georgia Papadopoulou, Evangelia Vassou, Evangelia-Georgia Kostaki, Kalliopi Papadima, Elissavet Mouratidou, Maria Tsintziloni, Nikolaos Siafakas, Zoi Florou, Antigoni Katsoulidou, Spyros Sapounas, George Sourvinos, Spyridon Pournaras, Efthymia Petinaki, Maria Goula, Vassilios Paparizos, Anna Papa, Theoklis Zaoutis, Dimitrios Paraskevis
Publikováno v:
Viruses, Vol 15, Iss 6, p 1384 (2023)
In May 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022, and a total of 88 cases were reported in the country until the end of A
Externí odkaz:
https://doaj.org/article/e340db3c63b64d7f9e08c0aa52bea6c4
Autor:
Petros Ioannou, Athanasios Katsigiannis, Ioanna Papakitsou, Ioannis Kopidakis, Eirini Makraki, Dimitris Milonas, Theodosios D. Filippatos, George Sourvinos, Marina Papadogiannaki, Evaggelia Lydaki, Georgios Chamilos, Diamantis P. Kofteridis
Publikováno v:
Viruses, Vol 15, Iss 3, p 756 (2023)
Patients receiving treatment with B-cell-depleting monoclonal antibodies, such as anti-CD20 monoclonal antibodies, such as rituximab and obinutuzumab, either for hematological disease or another diagnosis, such as a rheumatological disease, are at an
Externí odkaz:
https://doaj.org/article/96826c7bd7214d22bed748da610750e7
Autor:
Athanasios Panagiotopoulos, Melpomeni Tseliou, Ioannis Karakasiliotis, Danai‐Maria Kotzampasi, Vangelis Daskalakis, Nikolaos Kesesidis, George Notas, Christos Lionis, Marilena Kampa, Stergios Pirintsos, George Sourvinos, Elias Castanas
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Abstract Therapeutic regimens for the COVID‐19 pandemics remain unmet. In this line, repurposing of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been advanced, while natural products have also been tested. Here, we
Externí odkaz:
https://doaj.org/article/788c35684ac9478ca175c2659d613783
Autor:
Ioanna Pantazi, Ahmed A. Al-Qahtani, Fatimah S Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, Eleni Vergadi, Christos Tsatsanis
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S)
Externí odkaz:
https://doaj.org/article/68c2e831848946b6abd7e79c9ea26b3c
Autor:
Stergios Pirintsos, Athanasios Panagiotopoulos, Michalis Bariotakis, Vangelis Daskalakis, Christos Lionis, George Sourvinos, Ioannis Karakasiliotis, Marilena Kampa, Elias Castanas
Publikováno v:
Molecules, Vol 27, Iss 13, p 4060 (2022)
Ethnopharmacology, through the description of the beneficial effects of plants, has provided an early framework for the therapeutic use of natural compounds. Natural products, either in their native form or after crude extraction of their active ingr
Externí odkaz:
https://doaj.org/article/ae3416aeca4743ccbe8913fe951dd50f
Autor:
Athanasios A. Panagiotopoulos, Ioannis Karakasiliotis, Danai-Maria Kotzampasi, Marios Dimitriou, George Sourvinos, Marilena Kampa, Stergios Pirintsos, Elias Castanas, Vangelis Daskalakis
Publikováno v:
Molecules, Vol 26, Iss 19, p 6068 (2021)
3CL-Pro is the SARS-CoV-2 main protease (MPro). It acts as a homodimer to cleave the large polyprotein 1ab transcript into proteins that are necessary for viral growth and replication. 3CL-Pro has been one of the most studied SARS-CoV-2 proteins and
Externí odkaz:
https://doaj.org/article/b7829afdf8234aef9c4bb36d40d73f2d